Motley Fool Money cover image

Selling Secrets Across The Globe

Motley Fool Money

00:00

Navigating Drug Development Challenges

This chapter explores the regulatory hurdles faced by drug companies in bringing innovative therapies to market, highlighting the complexities of the approval process and the high likelihood of treatment failures. It also examines Vertex Pharmaceuticals’ focus on non-opioid pain research and the implications for investment in the biotech sector.

Play episode from 17:29
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app